- Nivolumab v liečbe karcinómu pankreasu - Gastrointestinal Cancer symp…
Number of the records: 1  

Nivolumab v liečbe karcinómu pankreasu - Gastrointestinal Cancer symposium ASCO, San Francisco 2017

  1. Authority Šálek, Tomáš (Author)
    TitleNivolumab v liečbe karcinómu pankreasu - Gastrointestinal Cancer symposium ASCO, San Francisco 2017 = Nivolumab in treatment of pancreatic cancer-Gastrointestinal Cancer symposium ASCO, San Francisco 2017 / Tomáš Šálek
    Par.titleNivolumab in treatment of pancreatic cancer-Gastrointestinal Cancer symposium ASCO, San Francisco 2017
    NoteBibliogr. odkazy. Res. angl., slov.
    In Gastroenterológia pre prax. -- ISSN 1336-1473. -- Roč. 17, č. 1 (2018), s. 40
    Call numberC 3037
    Subj. Headings Gastrointestinal cancer symposium (2017 : San Francisco, Kalifornia, USA)
    karcinóm - farmakoterapia
    nádory pankreasu - farmakoterapia
    receptor programovanej bunkovej smrti 1 - antagonisty a inhibítory
    kombinácie liekové
    Keywords nivolumab * inhibítory PD-1 * PD-1 (proteín programovanej bunkovej smrti 1) * kombinácia nivolumab, nab-paklitaxel a gemcitabín * kombinácia ipilimumab a gemcitabín * kombinácia inhibítory imunitných kontrolných bodov a cytostatiká
    LanguageSlovak
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.